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Abstract: The objective of this study was to survey health professionals to investigate their knowledge
of probiotics. An online survey was conducted to gather data on the knowledge of health professionals.
The online survey was distributed via email and social media platforms using snowball sampling. A
total of 1066 health professionals (859; 80.6% female) from 30 countries responded to the survey. Most
of the respondents evaluated their knowledge of probiotics as medium (36.4%) or good (36.2%). Only
8.9% of the respondents rated it as excellent. No statistical difference in knowledge was found between
male and female health professionals. Over 80% of pharmacists, allied health professionals, medical
doctors and dentists, and other health professionals knew the correct definition of probiotics as “live
microorganisms that, when administered in adequate amounts, confer a health benefit on the host”,
whereas three quarters of registered nurses and midwives and less than two thirds of psychologists
identified the correct definition. Statistically, more female than male health professionals knew
the correct definition of probiotics. The most frequently recognized species of bacteria containing
probiotic strains were Lactobacillus acidophilus (92%), Bifidobacterium bifidum (82%), and Lactobacillus
rhamnosus (62%). The opinions on when it is best to take probiotics were different (χ2 = 28.375;
p < 0.001), with 90.2% of respondents identifying that probiotics have beneficial effects if taken during
antibiotic therapy, 83.5% for diarrhea, 70.6% for constipation, 63.3% before traveling abroad, and
60.4% for treating allergies. Almost 79% of health professionals involved in this study have advised
their patients to use probiotics and 57.5% of the respondents wanted to learn more about probiotics.
All things considered, health professionals have a medium level of knowledge of probiotics, which
could be improved by the implementation of targeted learning programs. As probiotics have many
beneficial effects in a wide range of health areas, health professionals need to adopt the use of
probiotics in clinical practice.
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1. Introduction
The well-known definition of probiotics was originally accepted in 2001 at an expert consultation
of international scientists working on behalf of the Food and Agriculture Organization of the United
Nations (FAO) and the World Health Organization (WHO) [1]. In 2002, a FAO/WHO working group
produced guidelines to assist with the interpretation of the original document [2]. For almost two
decades, the definition has been widely used in the scientific community. In 2014, the International
Scientific Association for Probiotics and Prebiotics (ISAPP) published the most recent and widely
accepted definition of probiotics as follows: “live microorganisms that, when administered in adequate
amounts, confer a health benefit on the host.” [3].
Prior to the acceptance of this definition, only strain-specific probiotics were acknowledged to
confer health benefits [4]; however, on the basis of a large number of well-designed clinical trials, it has
been agreed that certain beneficial health effects of several strains of a number of well-studied microbial
species can be ascribed to probiotics as a general class [3]. Several species of the genera Bifidobacterium
and Lactobacillus are claimed to have a core benefit on healthy gut microbiota by creating a favorable
gut environment. High quality meta-analyses also suggest that they are effective against infectious
diarrhea, antibiotic-associated diarrhea, travelers’ diarrhea, slow gut transit, irritable bowel syndrome,
abdominal pain and bloating, and ulcerative colitis [3,5–13]. In addition, strain-specific probiotics
support positive health outcomes including the maintenance of a healthy immune system [3,14,15].
Despite a widely accepted definition and well-described benefits to health, the term probiotic is still
misapplied by scientists and the general public as referring to fermented products that contain a
diverse community of live, potentially beneficial microorganisms that are not specifically probiotics [3].
Probiotics are regarded as complementary and alternative medicine along with vitamins, minerals,
and other dietary supplements [16]. Today, probiotics are commercially available substances that are
found not only in dietary supplements, drugs, functional foods, and beverages, but also in products
such as skin creams, vaginal capsules and tampons, and chewable tablets for gum health [17].
According to the ninth edition of the European Pharmacopoeia (2019) [18], ‘live biotherapeutic
products’ for human use are medicinal products containing live microorganisms that can be
administered orally or vaginally in different pharmaceutical forms. New terms such as ‘paraprobiotic’
or ‘postbiotic’ have emerged to denote that non-viable microbial cells, microbial fractions, or cell lysates
might also offer physiological benefits to the host by providing additional bioactivity [19]. On the other
hand, ‘prebiotics’ are substrates that are selectively used by host microorganisms conferring a health
benefit [20], and ‘synbiotics’ are dietary supplements or food ingredients that combine the effects of
probiotics and prebiotics [21].
Despite the widespread and easily accessible evidence that supports the benefits of probiotic use,
health professionals may hesitate in recommending probiotics to patients when they receive conflicting
messages. Health professionals may have difficulties in processing large volumes of information
generated by commercial enterprises about the benefits and use of probiotics. Based on Regulation No.
1924/2006 of the European Union on nutrition and health claims made on foods [18], EU member states
have forbidden the use of the term ‘probiotic’ on all foods including probiotic food supplements unless
the procedures noted in the regulation have been observed. This can lead to considerable confusion
among health professionals when advising patients on the use of probiotics. Therefore, our aim was to
investigate the current knowledge, attitude, and practice of health professionals regarding probiotics.
2. Methods
The online survey was distributed via email and social media platforms using snowball sampling
and was open for three months between March and May 2018. The English version of the online
questionnaire was translated into six languages (Croatian, German, Hungarian, Italian, Slovenian, and
Swedish). Participants were free to respond in the language of their choice.
The questions were modeled based on those used in previously published studies on the
knowledge of probiotics [22–26]. The survey was divided into three sections. The first section consisted
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of demographic questions and the second section consisted of questions about the respondents’
knowledge of probiotics. In Section 2, the respondents were first asked to evaluate their knowledge of
probiotics on a 5-point Likert scale with the following grades: no knowledge (1), little knowledge (2),
medium knowledge (3), good knowledge (4), and very good knowledge (5). They were then asked
about the definition of and facts about probiotics. The third section included questions about the
respondents’ experience in the use of probiotics, their beliefs about the positive effects of probiotics,
and whether they have ever advised the use of probiotics to friends, relatives, or patients. At the end
of Section 3, the respondents were asked about their major sources of information regarding probiotics
and if they would like to develop more extensive knowledge on probiotics. The survey took seven
minutes on average to complete.
Ethics approval was obtained through the Ethics Committee for the field of nursing at the
University of Maribor, Faculty of Health Sciences (study number: 038/2017/5755-3/501). The Human
Research Ethics Committee of Western Sydney University also approved this research (RH12553).
The data were analyzed by the IBM SPSS V25 software and MS Excel. A p value of less than 0.05
was accepted as statistically significant. Proportions were calculated and percentages reported for
categorical variables. Proportions were compared by using the χ2 statistic. The numerical variables
were presented as means ± standard deviation (SD). For variables that are not normally distributed,
a median with a 95% confidence interval was used. The Mann–Whitney U test and its extension,
the Kruskal–Wallis H test, were used to compare the self-evaluation of the knowledge of probiotics by
sex and among different groups of health professionals.
3. Public Involvement
The public were involved in the research by answering the online survey. The survey was
anonymous and voluntary. The respondents were given the opportunity to add their email address if
they wished to receive a copy of the results.
4. Results
Health professionals from 30 countries (n = 1066) responded to this survey. Respondents were
drawn from the following regions: Western Europe (n = 695; 65.2%), Central and Eastern Europe
(n = 262; 24.6%), Australia (n = 96; 9.0%), and other (n = 13; 1.2%). Mean age ± SD of respondents
was 47 ± 14 years, ranging from 19 to 78 years. In total, 859 (80.6%) of respondents were female
and 207 (19.4%) were male. More than one third (35.7%) of the respondents had higher university
degrees (master’s or PhD), 22.4% had a university degree, 13.6% completed higher education, and
25.1% completed secondary school. A small proportion of respondents (3.2%) did not reveal their
education level.
Registered nurses or midwives represented the highest proportion of respondents from a single
profession (25.3%), followed by pharmacists (16.7%), medical doctors or dentists (16.7%), allied health
professionals (12.9%), psychologists (1.8%), and other health professionals including physiotherapists,
paramedics, and osteopaths (27.3%). Most respondents had between 11 and 30 years of experience
working as a health professional (47.8%), followed by those who had 10 years’ experience or less
(33.9%), and those who had over 30 years of experience (18.2%).
4.1. Respondents’ Self-Evaluation of Knowledge of Probiotics
The respondents graded their knowledge of probiotics using the 5-point Likert scale according
to five possible grades (1: No knowledge; 2: Little knowledge; 3: Medium knowledge; 4: Good
knowledge; and 5: Very good knowledge). Most evaluated their knowledge as medium (36.4%) or
good (36.2%). Some rated their knowledge as excellent (8.9%), some as poor (16.7%), and the remainder
had no knowledge of probiotics at all (1.8%).
The self-evaluation of knowledge is statistically different among various groups of health
professionals (H = 122.9; p < 0.001). Pharmacists, allied health professionals, and other health
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professionals evaluated their knowledge with a median grade of 4 (95% CI: [4,5]); medical doctors
and dentists, registered nurses, and midwifes demonstrated a median grade of 3 (95% CI: [3,4]); and
psychologists graded their probiotics-related knowledge with the lowest median value of 2 (95%
CI: [2,3]) (Figure 1).
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Figure 1. Self-evaluation of knowledge about probiotics by profession (1: No knowledge; 2: Little
knowledge; 3: Medium knowledge; 4: Good knowledge; and 5: Very good knowledge). The boxplots
show the quartiles for each group of healthcare professionals.
The median score for the self-evaluation of the knowledge of probiotics was 3 (95% CI: [3,4]) in
both sexes, so there was no statistical difference between male and female health professionals in this
respect (U = 83263.0; p = 0.134).
4.2. Respondents’ Knowledge of the Correct Definition of Probiotics
The responde ts then chos fr m five d ffere t claims for the definition of probiotics: (1) probiotics
are dead microorganisms, that when administered in adequate amounts, confer a health benefit to
the host; (2) probiotics are live microorganisms, that when administered in adequate amounts, confer
a health benefit to the host; (3) probiotics are all microorganisms consumed with foods and dietary
supplements; (4) probiotics are all microorganisms that adhere to intestinal epithelial mucosa; (5) I do
not know the definition of probiotics. The correct definition (answer 2) was chosen by 82.2% of the
respondents. The knowledge of the right definition of probiotics was statistically different among the
various groups of health professionals (χ2 = 17.645; p = 0.003). Over 80% of pharmacists, allied health
professionals, medical doctors and dentists, and other health professionals knew the correct definition
of probiotics, whereas three quarters of registered nurses and midwives and less than two thirds of
psychologists identified the correct definition (Figure 2).
When asked to choose the correct definition of probiotics, more female (83.6%) than male (76.8%)
respondents chose the correct answer to a statistically significant degree (χ2 = 4.853; p = 0.028).
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Figure 2. Knowledge of the c rr t efinition of probiotics among different ealth pr fession groups.
Blue proportions sho the percentage of health professionals that chose the correct definition in
each group.
4.3. Respondents’ Knowledge of Microbial Species including Probiotic Strains
Respondents were then asked to choose species from the provided list of microorganisms that
they thought had probiotic strains. The list included: Lactobacillus acidophilus, Bifidobacterium bifidum,
Mycobacterium avium, Escherichia coli, Lactobacillus rhamnosus, Bacillus subtilis, Enterococcus faecium,
and Saccharomyces boulardii. All mentioned species except for Mycobacterium avium contain different
probiotic strains. As shown in Figure 3, Lactobacillus acidophilus (92%), Bifidobacterium bifid (82%), and
Lactoba illus rhamn sus (62%) were he mo t recognizable species of bacteria containing probiotic strains.
A little less than a third f the respondents also chose Enterococcus faecium (29%) an Saccharomyces
boulardii (27%) and, indeed, both species include several probiotic strains even though they are not so
commonly known. One quarter (25%) also correctly listed Escherichia coli, which has one commonly
known probiotic strain, E. coli Nissle 1917 [27]. The only species in the list without probiotic strains
was Mycobacterium avium, which was incorrectly selected by a minority of respondents (4%).
The respondents’ knowledge about probiotic strains also differed considerably among the various
groups of health professionals (Figure 4). Lactobacillus acidophilus was the most recognizable microbial
species with probiotic strains among all of the health professional groups. The vast majority (>0%) of
health professionals in all groups except registered nurses, midwifes, and psychologists recognized
this species as including probiotic strains. The probiotic strains of Bifidobacterium bifidum were also
widely identified, with more than 90% of medical doctors and dentists, pharmacists, and allied health
professionals recognizing them. In contrast, less than two thirds of nurses and midwives (61.3%) and
psychologists (57.9%) had heard of the probiotic strains of Bifidobacterium bifidum. Mycobacterium avium
does not contain any probiotic strains and is an opportunistic pathogen, and was well known among
all surveyed health professionals [28]. Lactobacillus rhamnosus is a somewhat less well-known species
containing probiotic strains. However, this was recognized as a species containing probiotic strains by
a majority of pharmacists (80.1%). Escherichia coli is another important bacterial species that has at
least one probiotic strain, the above-mentioned E. coli Nissle 1917; however, approximately two thirds
of allied health professionals (65.9%) and other health professionals (68.9%) were unaware of this.
Similarly, the probiotic properties of certain Enterococcus faecium strains were known among all health
professional groups to a small extent; only one third of pharmacists, allied health professionals, and
other health professionals acknowledged that this species could contain probiotic strains. Saccharomyces
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boulardii was recognized as a yeast species with probiotic strains by some pharmacists and medical
doctors (52.2% and 42.7%, respectively).Int. J. Environ. Res. Public Health 2019, 16, x FOR PEER REVIEW 6 of 17 
 
 
Figure 3. Respondents’ knowledge of microbial species that possibly have probiotic strains. * This 
species has no probiotic strains. 
The respondents’ knowledge about probiotic strains also differed considerably among the 
various groups of health professionals (Figure 4). Lactobacillus acidophilus was the most recognizable 
microbial species with probiotic strains among all of the health professional groups. The vast majority 
(>90%) of health professionals in all groups except registered nurses, midwifes, and psychologists 
recognized this species as including probiotic strains. The probiotic strains of Bifidobacterium bifidum 
were also widely identified, with more than 90% of medical doctors and dentists, pharmacists, and 
allied health professionals recognizing them. In contrast, less than two thirds of nurses and midwives 
(61.3%) and psychologists (57.9%) had heard of the probiotic strains of Bifidobacterium bifidum. 
Mycobacterium avium does not contain any probiotic strains and is an opportunistic pathogen, and 
was well known among all surveyed health professionals [28]. Lactobacillus rhamnosus is a somewhat 
less well-known species containing probiotic strains. However, this was recognized as a species 
containing probiotic strains by a majority of pharmacists (80.1%). Escherichia coli is another important 
bacterial species that has at least one probiotic strain, the above-mentioned E. coli Nissle 1917; 
however, approximately two thirds of allied health professionals (65.9%) and other health 
professionals (68.9%) were unaware of this. Similarly, the probiotic properties of certain Enterococcus 
faecium strains were known among all health professional groups to a small extent; only one third of 
pharmacists, allied health professionals, and other health professionals acknowledged that this 
species could contain probiotic strains. Saccharomyces boulardii was recognized as a yeast species with 
probiotic strains by some pharmacists and medical doctors (52.2% and 42.7%, respectively). 
92%
82%
4%
25%
62%
10%
29%
27%
0% 20% 40% 60% 80% 100%
 Lactobacillus acidophilus
Bifidobacterium bifidum
Mycobacterium avium*
Escherichia coli
Lactobacillus rhamnosus
Bacillus subtilis
Enterococcus faecium
Saccharomyces boulardii
Percentage of answers of respondents
M
icr
ob
ial
 sp
ec
ies
 th
at
 p
os
sib
ly 
co
nt
ain
 
pr
ob
io
tic
 st
ra
in
s 
i r . t ’ l f i r i l i t t i l r i ti str i . * i
i i ti t i .
Int. J. Environ. Res. Public Health 2019, 16, x FOR PEER REVIEW 7 of 17 
 
 
Figure 4. Respondents’ knowledge of microbial species wit  possi le probiotic st a n  according to 
health profession. * This species has no probiotic strains. 
The familiarity with species of microbes that contained probiotic strains was statistically 
different by sex only for the fungi Saccharomyces boulardii (χ2 = 21.650; p < 0.001). Only 23.6% of female 
and 39.1% of male respondents knew that Saccharomyces boulardii contained probiotic strains. 
4.4. Respondents’ Knowledge of some of the Claims for Probiotics 
The respondents were asked to mark ‘true’ or ‘false’ for the following claims: (1) The only 
probiotics that work are tablets, powders, or capsules; (2) Probiotics need to be live microorganisms; 
(3) For a beneficial effect, it is necessary to consume probiotics for a long period of time as they 
disappear from the gut after two weeks; and (4) Probiotics should be taken before a meal. 
Fewer than one quarter of the respondents (22.5%) incorrectly answered that probiotics are only 
effective in the form of tablets, powders, or capsules. Almost three quarters (73.7%) of them correctly 
answered that probiotics must be live microorganisms. Most respondents (71.5%) agreed that 
probiotics needed to be consumed orally for a long period of time to exert a beneficial health effect, 
as they may disappear from the gut after two weeks. Nearly two thirds of the respondents (64%) 
claimed that probiotics should be taken before meals. This claim was noted as correct in accordance 
with [29], wherein the highest survival of probiotics was observed when they were given before a 
meal, although this issue remains debatable. 
Knowledge based on all statements differed significantly. Most of the respondents knew that 
efficient probiotics were not restricted to tablets, powders, and capsules. Only around 10% of 
registered nurses, midwifes, and psychologists marked this statement incorrectly as being true. The 
group that incorrectly identified this statement as being true in the highest percentage (36.2%) were 
allied health professionals. 
More than 70% of all respondents from each group, except for registered nurses and midwives, 
knew that it is necessary to consume probiotics for a long period of time in order to maximize their 
beneficial effects. Knowledge about when best to take probiotics differed significantly between 
professional groups (χ2 = 28.375; p < 0.001). Over three quarters of pharmacists (77.5%) and more than 
two thirds of allied health professionals (71.0%) and psychologists (68.3%) recommended taking 
probiotics before meals, whereas medical doctors, dentists, nurses, and midwives had a more divided 
opinion about this. There was no statistical difference between sexes in familiarity with statements 
regarding probiotic properties, as 83.4% of the female respondents and 76.8% of the male respondents 
were familiar with these statements. 
4.5. Respondents’ Use of Probiotics  
93
.0
%
88
.1
%
78
.9
% 96
.1
%
97
.1
%
92
.7
%
90
.1
%
61
.3
%
57
.9
%
92
.1
%
92
.8
%
86
.2
%
3.
5% 4.
1% 5.
3%
5.
1%
2.
2% 3.
5%
28
.1
%
13
.0
%
0.
0%
26
.4
%
34
.1
%
31
.1
%
62
.6
%
43
.5
%
31
.6
%
80
.9
%
64
.5
%
67
.8
%
14
.0
%
5.
9%
0.
0%
17
.4
%
8.
0% 9.
0%
26
.3
%
15
.2
%
0.
0%
37
.6
%
39
.1
%
35
.3
%
42
.7
%
7.
4%
0.
0%
52
.2
%
18
.8
%
24
.9
%
M E D I C A L  
D O C T O R  O R  
D E N T I S T
R E G I S T E R E D  
N U R S E  O R  
M I D W I F E
P S Y C H O L O G I S T P H A R M A C I S T A L L I E D  H E A L T H  
P R O F E S S I O N A L
O T H E R
Pe
rc
en
ta
ge
s o
f a
ns
we
rs 
of
 re
sp
on
de
nt
s
Respondents according to group of health professionals
Lactobacillus acido hilus Bifidobacterium bifidum Mycobacterium avium* Escherichia coli
Lactobacillus rhamnosus Bacillus ubtilis Enterococcus faecium Saccharomyces boulardii
Figure 4. Respondents’ knowledge of microbial species with possible probiotic strains according to
health profession. * This species has no probiotic strains.
The familiarity with species of microbes that contained probiotic strains was statistically different
by sex only for the fungi Saccharomyces boulardii (χ2 = 21.650; p < 0.001). Only 23.6% of female and
39.1% of male respondents knew that Saccharomyces boulardii contained probiotic strains.
4.4. Respondents’ Knowledge of some of the Claims for Probiotics
The respondents were asked to mark ‘true’ or ‘false’ for the following claims: (1) The only
probiotics that work are tablets, powders, or capsules; (2) Probiotics need to be live microorganisms;
(3) For a beneficial effect, it is necessary to consume pr biotics for a l ng period of time as they
disappear f om the gut fter two weeks; a d (4) Probiotics should b taken before a meal.
Few r than one quarter of the respondents (22.5%) inc rrectly answered that pr biotics are only effective
in the form of tablets, powders, or capsules. Almost three quarters (73.7%) of them correctly answered that
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probiotics must be live microorganisms. Most respondents (71.5%) agreed that probiotics needed to be
consumed orally for a long period of time to exert a beneficial health effect, as they may disappear from
the gut after two weeks. Nearly two thirds of the respondents (64%) claimed that probiotics should be
taken before meals. This claim was noted as correct in accordance with [29], wherein the highest survival of
probiotics was observed when they were given before a meal, although this issue remains debatable.
Knowledge based on all statements differed significantly. Most of the respondents knew that efficient
probiotics were not restricted to tablets, powders, and capsules. Only around 10% of registered nurses,
midwifes, and psychologists marked this statement incorrectly as being true. The group that incorrectly
identified this statement as being true in the highest percentage (36.2%) were allied health professionals.
More than 70% of all respondents from each group, except for registered nurses and midwives,
knew that it is necessary to consume probiotics for a long period of time in order to maximize
their beneficial effects. Knowledge about when best to take probiotics differed significantly between
professional groups (χ2 = 28.375; p < 0.001). Over three quarters of pharmacists (77.5%) and more
than two thirds of allied health professionals (71.0%) and psychologists (68.3%) recommended taking
probiotics before meals, whereas medical doctors, dentists, nurses, and midwives had a more divided
opinion about this. There was no statistical difference between sexes in familiarity with statements
regarding probiotic properties, as 83.4% of the female respondents and 76.8% of the male respondents
were familiar with these statements.
4.5. Respondents’ Use of Probiotics
The vast majority of respondents (86.8%) had already used probiotics. Over 92% of pharmacists
and allied health professionals had previously taken probiotics, followed by other health professionals
(89.3%). More than 84% of medical doctors and dentists had already used probiotics as had almost 80%
of registered nurses, midwives, and psychologists (Figure 5).
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Figure 5. Use of probiotics ng health professionals.
The responde ts reported personally havi g co sumed probiotic drinks or probiotic yogurts
(74.5%), probiotic medicines (73.9%), probiotic food supplements available only in pharmacies (74.4%),
probiotic food supplements available in specialized shops, supermarkets, or online (74.4%), and other
probiotic products (34.1%). Other probiotic products that respondents claimed to have consumed
included chewable tablets with probiotics for dental health, tampons and/or vaginal creams or capsules
with probiotics, and skin creams with probiotics. More female (88.2%) than male (80.7%) respondents
had previously used probiotics. The difference was statistically significant (χ2 = 8.319; p = 0.004).
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4.6. Reasons for Taking Probiotics
More than half of the respondents (53.0%) had taken probiotic products for preventive purposes
during an antibiotic treatment (44.5%), for improved digestion (36.8%), to reduce bloating and also for
other reasons such as allergic conditions, dermatological problems, or stress (20.2%).
Most respondents believed that probiotics had beneficial effects if taken during antibiotic therapy
(90.2%). Most agreed that probiotics should be used in the case of diarrhea (83.5%), for constipation
(70.6%), and before traveling abroad (63.3%). Most also believed that probiotics were beneficial in
treating allergies (60.4%). More than half of the respondents also thought that taking probiotics could
be good for people with depression or mood disorders. A little less than 50% believed that probiotics
were effective against hay fever, carcinoma, and liver disease.
4.7. Sources of Information on Probiotics
Respondents had acquired their knowledge of probiotics from various sources including books or
expert magazines (53.3%), websites (34.9%), at work (28%), from pharmacies (25%), and from radio or
TV (9.7%). More than half of all respondents (57.5%) wanted to learn more about probiotics.
4.8. Advising the Use of Probiotics
A total of 933 health professionals (87.5% of all respondents) had advised people such as friends
(67.6%), relatives (63.8%), sons and daughters (43.6%), and others including clients, co-workers, visitors
or patients to use probiotics.
Respondents were also asked if they had ever advised their patients to use probiotics, and almost
79% of them answered affirmatively, whereas 5.3% of the respondents did not remember ever doing
so. Only 11.6% of healthcare workers had never advised a patient to try probiotics. We also analyzed
this question separately for medical doctors, dentists, registered nurses, midwives, and psychologists
(Figure 6). Unlike registered nurses and psychologists, the majority (>80%) of medical doctors, dentists,
and midwives had advised their patients to use probiotics.
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4.9. Respondents’ Knowledge of Prescription Probiotics
Knowledge about the prescription of probiotics varied between respondents from different
countries. Some respondents believed that it was possible to prescribe probiotics in their country
(41.6%), while others believed that it was not possible (29.5%), and some others admitted that they were
not sure if it was possible or not (28.9%). As different countries have different regulations regarding
prescription, we analyzed those with the highest numbers of respondents (Figure 7).Int. J. Environ. Res. Public Health 2019, 16, x FOR PEER REVIEW 10 of 17 
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I all four noted countries (Australia, Austria, Germany, and Slovenia) it is not possible to prescribe
robiotics. Only 22.4%, 21.9%, and 15.8 of Slovenian, Austria , and Australian health professionals,
resp ctively, answered this question correctly. In cont ast, over 40% of German health p ofessionals
correctly answered that it was not possible to prescribe probiotics in Ge many.
5. Discussion
Here, we present a cross-sectional study of the knowledge and beliefs of healthcare professionals
with regard to probiotics. One important limitation of our work was the number of respondents that
completed the survey. The number of clicks on the survey was much higher than the actual number of
completed questionnaires (n = 1066). This may have been because some healthcare professionals did
not feel that they had enough knowledge to correctly answer the survey questions or perhaps some
of them did not agree with the questions, therefore, it would be much more likely for someone who
knows about probiotics to respond than someone who knows little to nothing. Due to anonymity, we
had no information as to who was responding to the survey. Additionally, there was a disconnection
between the people’s perception of how good their knowledge of probiotics was and their ability to
answer the questions correctly. Another limitation was the high female-to-male ratio of approximately
4:1. As a result, our sampling was not statistically validated.
In our study, a statistically significant difference was found in the respondents’ self-evaluation
of their knowledge of probiotics among the various health profession groups (H = 122.9; p < 0.001).
Pharmacists, allied health professionals, and other health professionals graded their knowledge as
good (4), whereas medical doctors and nurses evaluated their knowledge with a lower grade (3).
The medical doctors in our study were more self-critical than those surveyed by Johnson et al. [22],
who found that 85% of doctors in the study group had a good knowledge of probiotics. However,
there was no difference in the self-evaluation of nurses involved in this study. Similar to our findings,
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the majority (62.9%) of practice nurses questioned by Johnson et al. [22] believed that they had an
average understanding of probiotics.
Although there is a large body of scientific evidence supporting the benefits of probiotics, the wide
range of probiotic products and certain strain-specific effects of probiotics have made it difficult for
health professionals to make evidence-based decisions regarding probiotics [30]. The findings from our
study tend to support this contention as medical doctors and nurses did not evaluate their knowledge
with the highest score. In another study, pediatricians evaluated their knowledge as quite high [31].
The pressure on nurses to broaden their skill set and to take on more responsibility for patient care
has led to a need for nurses to specialize in various areas of health care. Patients may also find it
increasingly difficult to obtain reliable information on probiotics and may therefore ask questions when
visiting their nurse. While general practitioners are more likely to prescribe probiotics to patients,
specialist gastrointestinal and stoma care nurses should be aware of the potential benefits of probiotics
and how they work. People with conditions such as inflammatory bowel disease may ask specialist
nurses for advice on the potential of probiotics to improve their condition, and these secondary care
professionals should have easy access to reliable information based on the latest evidence regarding
particular probiotics that patients could consider using [22].
Our study also revealed that the majority (82.2%) of respondents correctly identified the definition
of probiotics and that knowledge of the correct term was statistically different among the various health
profession groups (χ2 = 17.645; p = 0.003). More than 80% of pharmacists, allied health professionals,
medical doctors, dentists, and other health professionals identified the correct definition of probiotics,
whereas the corresponding percentage for registered nurses and midwives was 75. In the study by
Soni et al. [23], the knowledge of probiotics among health students of various disciplines also differed
significantly, with approximately 93% of participants being aware of the term ‘probiotics’ and about
80% of them defining it correctly. A similar study in [32] also reported a low level of knowledge of
probiotics among university students and emphasized the need for education about the nutritional
and health benefits of fermented dairy products, especially those containing probiotics.
Regardless of the professional group, over 70% of our respondents correctly answered that
probiotics had to be live microorganisms. This was a higher proportion than that reported in another
study [24], where 65.6% of the health professionals stated that probiotics contained live microorganisms,
with the highest percentage of correct answers coming from pharmacists and physicians. Only 18.6%
of nurses correctly identified that probiotics were microorganisms. On the other hand, 14.5% of
the respondents in that study incorrectly stated that probiotics were synthetic drugs and 14.9%
stated that probiotics were natural plant products. These misperceptions could be corrected with
the implementation of educational interventions potentially delivered over a long period of time
to ensure the ongoing retention of information. However, this is not easy because health claims
for probiotics in the EU are not allowed to be explained due to current nutrition and health-claim
legislation in EU member states, in fact even the term ‘probiotic’ is forbidden [30]. For this reason,
health professionals should be able to access scientific information directly from probiotic companies,
as many probiotic companies have health professional-specific websites through which scientific
information and educational publications are available. In addition, as an indication of product quality,
the product label should show the full name of the probiotic strain(s) as well as the minimum live
count of the probiotic strains throughout the shelf-life of the products [22].
Some previously published studies [24,25,33] have assessed the knowledge, awareness, and
perception of probiotics among health providers in Nigeria. The results of these studies revealed a low
level of familiarity by clinicians and health professionals with probiotics. Conversely, other studies
conducted in the USA, Europe, and Asia [26,34] have reported a high degree of familiarity with the
term ‘probiotics’ among health professionals. This may be because probiotic foods are reasonably
well-established in North America, Europe, and Asia in comparison to Africa, and companies
manufacturing probiotic products in North America, Europe, and Japan have generally not made
probiotic products available in Africa, probably due to the low market power of the population [33,35].
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Medical students in Nigeria [24] have the highest level of knowledge of probiotics, followed by
pharmacy students, which may be due to the high quality of university instruction and the use of
a growing volume of evidence that supports the health effects of probiotics. Several studies have
also emphasized that health providers clearly need more information about probiotics in order to
confidently provide advice to patients [24,36]. In particular, nurses have a crucial role supporting the
use of probiotics because they are involved in the routine care of patients as well as in providing advice
and education [22].
We found a statistically significant difference in the knowledge of the correct definition of probiotics
in favor of females (χ2 = 4.853; p = 0.028). Other studies have reported different results, ranging from
non-significant differences [23,34] to male participants having a higher knowledge [37].
Correct information about probiotics is also important for patients because their main source
of information is commercial advertising rather than healthcare professionals [38]. Several studies
have shown that patients and other consumers have limited knowledge about probiotics [39–41].
Although general practitioners, nurses, and other health professionals may sometimes advise patients
to take probiotics [22], they can also freely purchase these products in pharmacies, specialty shops,
supermarkets, and online for whatever purpose they choose.
Some health professionals are confused about yoghurts, cultured milks, and fermented foods
because they do not understand that such products do not necessarily contain probiotics, whereas
others believe that probiotics only work in the form of tablets, powders, or capsules [22]. Several health
professionals think that foods containing probiotics are a better way to ingest probiotics than probiotic
drugs because of the synergistic effects between food components and probiotics and because food
enhances the stability of consumed probiotics [23]. There is a growing body of scientific evidence
showing the beneficial health effects of probiotic fermented dairy foods on a wide variety of diseases
including gut disorders (e.g., irritable bowel syndrome, constipation, and diarrhea), infections (e.g.,
antibiotic-associated diarrhea, Clostridium difficile, and Helicobacter pylori) as well as metabolic disorders
and cancer [22,42–49]. The mechanism of action most commonly attributed to probiotic microorganisms
is the production of antimicrobial substances, followed by competitive exclusion and competition for
essential nutrients [37].
The probiotic strains belonging to the Lactobacillus and Bifidobacterium genera that are most
commonly used as probiotics are well known [3,4,19]. Some of the respondents also recognized
gram-positive Enterococcus faecium and gram-negative Escherichia coli. As both species contain strains
that are natural inhabitants of the gastrointestinal tract, it is understandable that some of their strains
are probiotic such as Enterococcus faecium PTA 5844 and Escherichia coli Nissle 1917 [50–52]. However,
both species contain several pathogenic strains such as vancomycin-resistant Enterococcus faecium
or enteropathogenic, enterohemorrhagic, and enterotoxigenic Escherichia coli as well as Escherichia
coli strains resistant to extended-spectrum beta-lactamases [27,53,54] that can cause severe diseases.
The only yeast species mentioned in our survey that contains probiotic strains, Saccharomyces boulardii,
was recognized in a lower percentage by the surveyed health professionals, mainly by the surveyed
pharmacists and medical doctors, and recognized by more male than female respondents. On the other
hand, a few respondents added M. avium as a species that also contained probiotic strains, even though
M. avium is an opportunistic pathogen, mainly in animals, and no probiotic strains are known [28].
Most of our respondents (64%) claimed that probiotics should be taken before meals. Commercial
literature on various probiotic products suggests that they can be taken before meals, during meals,
after meals, or even without meals [29]. This has led to confusion amongst both health professionals
and consumers. To our knowledge, there is only one scientific study that has addressed this question.
The authors in [29] confirmed the highest survival of non-enteric coated probiotics if given with a meal
or before a meal, and the lowest survival if taken after a meal. In theory, the buffering of stomach
pH by certain foods should improve the gastric survival of probiotic microorganisms, but to what
extent remains unknown [55,56]. The protective matrix of fat in milk and dairy products also has a
positive effect on probiotic viability [55]. One study found higher survival rates for probiotic microbes
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as components of foods and in various micro- or nano-encapsulation matrices [57]. Another study
found a higher survival of probiotics in a yogurt matrix and capsules [56]; however, another efficiently
used the rehydration of powdered solution [58] and another concluded that foods were better carriers
for probiotics than supplements [59]. In general, these studies show that there are many efficient
possibilities and that more studies are necessary to make correct claims. As a rule, each formulation
should be tested in a clinical study that takes into account the time of application.
Our results have also shown that health professionals mostly purchase probiotics in pharmacies
for their own consumption because a free consultation is offered there. The pharmacists in our study
demonstrated a high level of knowledge of probiotics including the specific strains and their mechanisms
of actions, which is understandable given that most probiotic products are sold over-the-counter in
their pharmacies and that they need to be up to date in order to be able to consult their patients [60,61].
In Slovenia, it is not possible to prescribe probiotics. Over-the-counter probiotic food supplements
can only be recommended. A very limited amount of probiotic drugs that have been manufactured
in Slovenia, are part of the Slovenian drug register [62,63]. In Australia, probiotics occupy a liminal
space between medicine and food. Probiotics are regulated as a food when the product makes no
specific claims of health benefit, but it is regulated as a “therapeutic good” if it does. There are 245
probiotic products listed on the Australian Register of Therapeutic Goods (ARTG), all of which can
be purchased commercially without a prescription from a medical practitioner [64]. In Austria and
Germany, probiotics are regarded as nutrients and form the generic term for dietary supplements and
dietetic foods. The boundary between the nutritional or physiological effects of food supplements
(as food) and pharmacological action of medicinal products is important for their authorization,
notification, registration, and labeling. Products authorized as medicinal products cannot be sold as
foods, and foods cannot be sold as medicinal products. Probiotic supplements have a nutritional or
physiological effect, while medicines are used to cure, alleviate, or prevent human diseases. In Austria,
a delimitation advisory committee has been set up with the Federal Ministry for the preparation
of reports on the delimitation of medicines from foods. Probiotics can be recommended by health
professionals, whereas probiotic supplements (as food) are freely available [65]. Almost four fifths
(79%) of our respondents, mainly medical doctors, dentists and midwives, had prescribed or advised
their patients to use probiotics. Other authors have reported lower values ranging from 25.8% [24] to
50% [23] and 65.5% [22,30]. In comparison, 63.8% of the respondents to our survey stated that they
prescribed or recommended the use of antibiotics regularly [24].
The main reasons the respondents in our study advised patients on the use of probiotics included
a course of antibiotics, diarrhea, constipation, and traveling abroad. A total of 60% of our respondents
also believed that probiotics were effective against allergies, depression, or mood disorders. Further
reasons why health practitioners in other studies advised the use of probiotics include irritable bowel
symptoms, susceptibility to common infections, risk of diverticulitis, ulcerative colitis, old age, and
mothers or babies in families with a tendency to allergy [22,23,30].
6. Conclusions
Several factors such as increasing antibiotic resistance among pathogenic bacteria as well as the
increased demands of consumers for natural substitutes for medicines have led health professionals
to explore alternatives to pharmaceutical drugs. The emergence of scientific and clinical evidence
showing the effectiveness of certain probiotic strains has made them attractive as biotherapeutics.
As the current EU legislation on nutrition and health claims prevents manufacturers from explaining
their probiotic products to the consumers [30], the role of health professionals in giving informed and
objective advice on probiotics has largely increased. Patients who are interested in probiotics may
have difficulties finding reliable information on what probiotics do and how they actually work, and
may ask questions about probiotics when they visit their doctor’s office. Therefore, it is important
that health practitioners receive scientific evidence-based advice so that patients receive objective
and informed advice from their general practitioner, nurse, or pharmacist, rather than obtaining
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questionable information from unreliable sources [30]. As health practitioners have indicated an
interest in knowing more about probiotics [25], and are also the ones responsible for preparing various
guidelines for probiotic use based on evidence-based research [66], incorporation of this topic in
the curriculums of future health professionals and targeted learning programs of current healthcare
professionals may help in improving their knowledge and awareness.
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